Clearmind Medicine (CMND) Shares Outstanding (2021 - 2026)
Clearmind Medicine (CMND) posted quarterly Shares Outstanding (Entity) of $9.1 million for Q2 2026, up 2298.63% year-over-year from $378048.0 in Q2 2025, and up 159.84% quarter-over-quarter from $3.5 million in Q1 2026.
Clearmind Medicine (CMND) Shares Outstanding (2021 - 2026) Analysis & Trends
Clearmind Medicine's Shares Outstanding (Entity) history runs 6 years deep, the most recent figure standing at $9.1 million for Q2 2026.
- In Q2 2026, Shares Outstanding (Entity) rose 2298.63% year-over-year to $9.1 million; the TTM figure through Apr 2026 stood at $9.1 million (up 2298.63% YoY), while the FY2025 annual figure was $381652.0, up 63.99% from the prior year.
- Shares Outstanding (Entity) for Q2 2026 stood at $9.1 million, up from $3.5 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $9.1 million in Q2 2026, with the low at $3123.0 in Q1 2022.
- The 5-year median for Shares Outstanding (Entity) is $232733.0 (2024), against an average of $880669.5.
- The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Entity) surged 40.27% in 2022, then jumped 2506.83% in 2024.
- Clearmind Medicine's Shares Outstanding (Entity) stood at $3243.0 in 2022, then surged by 368.55% to $15195.0 in 2023, then soared by 1431.64% to $232733.0 in 2024, then surged by 63.99% to $381652.0 in 2025, then surged by 2275.98% to $9.1 million in 2026.
- Business Quant data shows CMND's Shares Outstanding (Entity) at $9.1 million in Q2 2026, $3.5 million in Q1 2026, and $381652.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 133.61 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 217.35 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 445.06 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 241.70 Mn |
| 10 | Clearmind Medicine | 520,887.91 | -13.07 Mn | - | 301,964.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 301,964.00 |
| Jan 31, 2026 | 116,210.00 |
| Oct 31, 2025 | 12,709.00 |
| Jul 31, 2025 | 13,356.00 |
| Apr 30, 2025 | 12,589.00 |
| Jan 31, 2025 | 11,221.00 |
| Oct 31, 2024 | 7,750.00 |
| Jul 31, 2024 | 8,900.00 |
| Apr 30, 2024 | 8,133.00 |
| Jan 31, 2024 | 3,794.00 |
| Oct 31, 2023 | 506.00 |
| Jul 31, 2023 | 591.00 |
| Apr 30, 2023 | 312.00 |
| Jan 31, 2023 | 191.00 |
| Oct 31, 2022 | 108.00 |
| Jul 31, 2022 | 109.00 |
| Apr 30, 2022 | 109.00 |
| Jan 31, 2022 | 104.00 |
| Oct 31, 2021 | 77.00 |